Bruker Announces Initiation of Quarterly Dividend
February 22 2016 - 6:01AM
Business Wire
Bruker Corporation (NASDAQ:BRKR) today announced that its Board
of Directors has approved the initiation of a dividend policy under
which the Company will target a cash dividend to the Company’s
stockholders in the amount of $0.16 per share per annum, payable in
equal quarterly installments.
The Company’s Board of Directors also declared an initial
quarterly cash dividend of $0.04 per share of common stock, payable
on March 24, 2016 to stockholders of record as of the close of
business on March 4, 2016.
Mr. Anthony Mattacchione, the Company’s Chief Financial Officer,
said: “The decision by Bruker’s Board of Directors to initiate a
dividend represents a significant milestone in the Company’s
history, as it demonstrates confidence in our growth prospects,
free cash flow generation and financial outlook over the long-term,
and reinforces our commitment to delivering value to our
shareholders.”
Future dividend declarations and the establishment of record and
payment dates for future dividend payments, if any, are subject to
the Board of Directors’ continuing determination that the dividend
policy is in the best interests of the Company’s stockholders. The
dividend policy may be suspended or cancelled at the discretion of
the Board of Directors at any time.
About Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve
the quality of human life. Bruker’s high-performance scientific
research instruments and high-value analytical solutions enable
scientists to explore life and materials at molecular, cellular and
microscopic levels.
In close cooperation with our customers, Bruker is enabling
innovation, productivity and customer success in life science
molecular research, in applied and pharma applications, and in
microscopy, nano-analysis and industrial applications, as well as
in cell biology, preclinical imaging, clinical research,
microbiology and molecular diagnostics. For more information,
please visit: http://www.bruker.com.
Forward Looking Statements
This press release contains forward-looking statements,
including, but not limited to, statements regarding the expected
future level and timing of any dividend payments, the Company's
commitment to paying dividends at any level in the future, and the
availability of funds for the payment of dividends. These
forward-looking statements are based on current information and
expectations, and involve a number of risks and uncertainties.
Actual future results and/or events may differ materially from such
expectations as a result of important risk factors, which include,
in addition to those identified in the Company’s Form 10-K for the
year ended December 31, 2014 and its other filings with the
Securities and Exchange Commission, a change in the Company's
dividend policy by the Company's Board of Directors (which has the
ability in its sole discretion to increase, decrease or eliminate
entirely the Company’s dividend at any time) and unanticipated
material payment obligations incurred by the Company that decrease
the Company's willingness or ability to pay dividends at the
anticipated level and timing, or at all. These risks and
uncertainties could cause actual results to differ materially from
those referred to in these forward-looking statements. The Company
expressly disclaims any obligation to update or revise these
forward-looking statements, except as otherwise specifically stated
by the Company or as required by law or regulation.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160222005457/en/
Bruker CorporationJoshua Young, +1 (978) 667 – 9580, ext.
1479Vice President, Investor Relations & Corporate
Developmentjoshua.young@Bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024